|
⚲
|
| Keyboard |
| Monnet Dominique
✚
|
|
|---|---|
| CIK # | 0001632798 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001632798] | |
| 4 | [0001632798] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| PDL Biopharma Inc | |
| Monnet Dominique | |
| Evofem Biosciences Inc | |
| Alexion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PDL Biopharma Inc PDLI
Common stock
|
2020-12-16 | Sell | 500,000 | $2.60 | 1,300,000 |
|
PDL Biopharma Inc PDLI
Common stock
|
2020-02-07 | Tax withheld | 672,505 | $3.51 | 2,360,493 |
|
PDL Biopharma Inc PDLI
Common stock
|
2020-01-08 | Grant | 1,233,766 | $0.00 | |
|
PDL Biopharma Inc PDLI
Stock Option (right to buy) · derivative
|
2019-03-28 | Grant | 2,450,000 | $0.00 | |
|
PDL Biopharma Inc PDLI
Common stock
|
2019-03-28 | Grant | 431,317 | $3.72 | 1,604,499 |
|
PDL Biopharma Inc PDLI
Common stock
|
2018-12-27 | Tax withheld | 17,615 | $3.02 | 53,197 |
|
PDL Biopharma Inc PDLI
Stock Option (right to buy) · derivative
|
2018-09-25 | Grant | 1,479,944 | $0.00 | |
|
PDL Biopharma Inc PDLI
Common stock
|
2017-09-12 | Grant | 240,200 | $0.00 | |
|
PDL Biopharma Inc PDLI
Stock Option (right to buy) · derivative
|
2017-09-11 | Grant | 961,000 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-05-20 | Sell | 256 | $162.40 | 41,574 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-02-27 | Grant | 3,830 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Option to Purchase Common Stock · derivative
|
2015-02-27 | Grant | 18,300 | $0.00 | |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-02-10 | Sell | 325 | $171.15 | 55,624 |
|
Alexion Pharmaceuticals Inc ALXN
Common Stock, par value $.0001 per share
|
2015-02-05 | Grant | 2,538 | $0.00 |